CRISPR/Cas9 genome editing to treat sickle cell disease
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.
第一著者: | Ullah, Mohammad |
---|---|
その他の著者: | Islam, Farzana |
フォーマット: | 学位論文 |
言語: | English |
出版事項: |
Brac University
2023
|
主題: | |
オンライン・アクセス: | http://hdl.handle.net/10361/19355 |
類似資料
-
CRISPR/Cas9 system: A versatile gene editing tool in disease prevention and treatment
著者:: Maria, Amatul
出版事項: (2020) -
Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment
著者:: Shaikat, Mahdi Mubin
出版事項: (2023) -
A review on CRISPR-Cas system based applications in Oncology
著者:: Sadia, Mir
出版事項: (2022) -
A review on CRISPR Technology as an Antiviral Tool
著者:: Srishti, Sanjida Ahmed
出版事項: (2023) -
CRISPR: a revolutionary tool for modeling and treating cancer and Duchenne muscular dystrophy
著者:: Eva, Israt Ara Jannat
出版事項: (2023)